Rani Therapeutics Holdings, Inc.
RANI
$1.39
$0.000.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 19.13% | 7.87% | 18.81% | -31.90% | 0.32% |
| Total Depreciation and Amortization | -7.08% | -4.38% | -5.64% | 2.70% | 1.57% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Non-Cash Items | 153.07% | 49.43% | -211.09% | 185.40% | 50.80% |
| Change in Net Operating Assets | -121.38% | 4,242.86% | 102.47% | -72.56% | -909.88% |
| Cash from Operations | 12.65% | 28.87% | 5.85% | -2.91% | 6.86% |
| Capital Expenditure | 100.00% | 27.45% | -64.52% | 75.20% | -32.98% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -68.54% | 616.30% | 329.63% | -91.03% |
| Cash from Investing | -100.00% | -68.66% | 623.09% | 437.53% | -92.81% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 0.00% | -200.00% | -- |
| Issuance of Common Stock | -25.57% | 9,295.24% | -99.55% | -7.01% | 6,012.12% |
| Repurchase of Common Stock | 12.50% | 65.22% | -155.56% | 35.71% | 41.67% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -636.70% | 105.04% | -166.40% | -27.06% | 5,363.83% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5,882.86% | -98.35% | 1,332.82% | -117.30% | 89.97% |